Previous 10 |
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates - Full-year 2020 Total Revenues Increased 9% to $1.86 billion - Company Dose-escalates in PHEarless, a Phase 1/2 Study with BMN 307 Gene Therapy for the Treatment of Phenylket...
Generation Bio is a stock to monitor for its potential to disrupt the viral gene therapy market. The company is centered around a technology platform that creates non-viral gene therapies that are re-dosable and have the COGs of a biologic. Early pre-clinical data has been promisi...
BioMarin to Participate in Four Upcoming Virtual Investor Conferences - 2021 SVB Leerink Global Healthcare Conference on February 26 at 11:20am ET - Cowen 41st Annual Health Care Conference on March 4 at 12:50pm ET - Barclays Global Healthcare Conference on March 9 at 2:...
The IPO market is as hot as it has been since 1999. I was curious about the performance of 1999's IPO class of stocks. So, I explored the outcomes of 73 IPOs from 1999 to see what happened to them over the past 22 years. For further details see: The Odds Of Winning The I...
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors PR Newswire SAN RAFAEL, Calif. , Feb. 18, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a global leader in providing therapi...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease PR Newswire Now Approved for Children of All Ages with CLN2 Batten Disease, Regardless of Whether They Yet Show Symptoms SAN RAFAEL, C...
BioMarin to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Monday, August 5, 2024, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , July 23, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander ...
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...